The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice

W. Kievit, J. Fransen, H.H. Kuper, M.A.F.J. van de Laar, D.J.R.A. Rooij, C.M.A. de Gendt, T.L. Jansen, K.H. Ronday, H.L.C. Brus, J.D. Moolenburgh, M. Janson, P.C.M. van Oijen, E.M. Adang, P.L. van Riel

    Research output: Contribution to conferencePosterOther research output

    Original languageEnglish
    Pages-
    Publication statusPublished - 21 Jun 2006
    EventEULAR Annual European Congress of Rheumatology 2006 - Amsterdam, Netherlands
    Duration: 21 Jun 200624 Jun 2006

    Conference

    ConferenceEULAR Annual European Congress of Rheumatology 2006
    Abbreviated titleEULAR 2006
    CountryNetherlands
    CityAmsterdam
    Period21/06/0624/06/06

    Keywords

    • METIS-235830

    Cite this